Welcome to The Healthcare Technology Report, a leading information source on healthcare technology companies and solutions.
In this episode, we speak with Ola Wlodek, CEO of Constructive Bio, a company developing technologies for large-scale genome writing and genetic code reprogramming. Spun out of Professor Jason Chin’s laboratory at the MRC Laboratory of Molecular Biology, Constructive Bio focuses on building programmable biomolecules and enabling cells to produce materials and therapeutics that conventional biology cannot.
Ola brings experience from across the Cambridge biotech ecosystem and previously served as Chief Operating Officer at Reflection Therapeutics. At Constructive Bio, she leads efforts to advance applications of synthetic genomics, from virus-resistant production strains to the biosynthesis of new classes of enzymes, pharmaceuticals, and biomaterials.
I am your host, RJ Lumba. We hope you enjoy the show. If you like the episode, click to follow.
